These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23554524)

  • 1. Implementing methadone maintenance treatment in prisons in Malaysia.
    Wickersham JA; Marcus R; Kamarulzaman A; Zahari MM; Altice FL
    Bull World Health Organ; 2013 Feb; 91(2):124-9. PubMed ID: 23554524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia.
    Wickersham JA; Zahari MM; Azar MM; Kamarulzaman A; Altice FL
    Drug Alcohol Depend; 2013 Sep; 132(1-2):378-82. PubMed ID: 23414931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone maintenance treatment in Spain: the success of a harm reduction approach.
    Torrens M; Fonseca F; Castillo C; Domingo-Salvany A
    Bull World Health Organ; 2013 Feb; 91(2):136-41. PubMed ID: 23554526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher methadone dose at time of release from prison predicts linkage to maintenance treatment for people with HIV and opioid use disorder transitioning to the community in Malaysia.
    Ahmad A; Bromberg DJ; Shrestha R; Salleh NM; Bazazi AR; Kamarulzaman A; Shenoi S; Altice FL
    Int J Drug Policy; 2024 Apr; 126():104369. PubMed ID: 38484531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-level implementation factors that influence scale-up of methadone maintenance treatment in Moldovan prisons: A qualitative study.
    O'Hara GL; Liberman AR; Polonsky M; Azbel L; Marcus R; Doltu S; Cugut S; Altice FL
    J Subst Abuse Treat; 2022 May; 136():108660. PubMed ID: 34801282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran.
    Moradi G; Farnia M; Shokoohi M; Shahbazi M; Moazen B; Rahmani K
    Int J Health Policy Manag; 2015 Mar; 4(9):583-9. PubMed ID: 26340487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
    Farnia M; Ebrahimi B; Shams A; Zamani S
    Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human resource development and capacity-building during China's rapid scale-up of methadone maintenance treatment services.
    Li J; Wang C; McGoogan JM; Rou K; Bulterys M; Wu Z
    Bull World Health Organ; 2013 Feb; 91(2):130-5. PubMed ID: 23554525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with interest in receiving prison-based methadone maintenance therapy in Malaysia.
    Mukherjee TI; Wickersham JA; Desai MM; Pillai V; Kamarulzaman A; Altice FL
    Drug Alcohol Depend; 2016 Jul; 164():120-127. PubMed ID: 27207155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program.
    Bachireddy C; Shrestha R; Bromberg DJ; Azbel L; Kurmanalieva A; Wegman M; Shumskaya N; Rozanova J; Meyer JP; Altice FL
    Int J Drug Policy; 2022 Mar; 101():103558. PubMed ID: 34915426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments.
    Azbel L; Wegman MP; Polonsky M; Bachireddy C; Meyer J; Shumskaya N; Kurmanalieva A; Dvoryak S; Altice FL
    Int J Prison Health; 2018 Sep; 14(3):175-187. PubMed ID: 30274558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and implementation of a factorial randomized controlled trial of methadone maintenance therapy and an evidence-based behavioral intervention for incarcerated people living with HIV and opioid dependence in Malaysia.
    Bazazi AR; Wickersham JA; Wegman MP; Culbert GJ; Pillai V; Shrestha R; Al-Darraji H; Copenhaver MM; Kamarulzaman A; Altice FL
    Contemp Clin Trials; 2017 Aug; 59():1-12. PubMed ID: 28479216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan.
    Huang YF; Kuo HS; Lew-Ting CY; Tian F; Yang CH; Tsai TI; Gange SJ; Nelson KE
    Addiction; 2011 Aug; 106(8):1437-45. PubMed ID: 21438941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.
    Brinkley-Rubinstein L; McKenzie M; Macmadu A; Larney S; Zaller N; Dauria E; Rich J
    Drug Alcohol Depend; 2018 Mar; 184():57-63. PubMed ID: 29402680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.
    Rich JD; McKenzie M; Larney S; Wong JB; Tran L; Clarke J; Noska A; Reddy M; Zaller N
    Lancet; 2015 Jul; 386(9991):350-9. PubMed ID: 26028120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of antiretroviral therapy uptake and retention of male clients receiving methadone maintenance therapy in two provinces in Vietnam: potential synergy of the two therapies.
    Pham LT; Kitamura A; Do HM; Lai KA; Le NT; Nguyen VT; Kato M
    Harm Reduct J; 2017 Feb; 14(1):12. PubMed ID: 28212645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The trajectory of methadone maintenance treatment in Nepal.
    Ambekar A; Rao R; Pun A; Kumar S; Kishore K
    Int J Drug Policy; 2013 Nov; 24(6):e57-60. PubMed ID: 23845916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey, 2009.
    Navadeh S; Mirzazadeh A; Gouya MM; Farnia M; Alasvand R; Haghdoost AA
    Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii33-6. PubMed ID: 23986417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and Effectiveness of Continuing Methadone Maintenance Treatment During Incarceration Compared With Forced Withdrawal.
    Moore KE; Oberleitner L; Smith KMZ; Maurer K; McKee SA
    J Addict Med; 2018; 12(2):156-162. PubMed ID: 29341974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention in clinical trials after prison release: results from a clinical trial with incarcerated men with HIV and opioid dependence in Malaysia.
    Chandra DK; Bazazi AR; Nahaboo Solim MA; Kamarulzaman A; Altice FL; Culbert GJ
    HIV Res Clin Pract; 2019 Feb; 20(1):12-23. PubMed ID: 31303149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.